Biogen Inc. financial data

Symbol
BIIB on Nasdaq
Location
225 Binney Street, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 154 % -22.1%
Quick Ratio 48.8 % -31.5%
Debt-to-equity 82.1 % -17.1%
Return On Equity 9.04 % +17.9%
Return On Assets 5.43 % +27.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 147M shares +0.65%
Common Stock, Shares, Outstanding 146M shares +0.62%
Entity Public Float 33.7B USD -18.2%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 147M shares +0.62%
Weighted Average Number of Shares Outstanding, Diluted 147M shares +0.55%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 10B USD +3.36%
Costs and Expenses 8.2B USD -1.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 744M USD +6.48%
Income Tax Expense (Benefit) 267M USD +71%
Net Income (Loss) Attributable to Parent 1.53B USD +32.1%
Earnings Per Share, Basic 10 USD/shares +31.5%
Earnings Per Share, Diluted 10 USD/shares +31.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 1.4B USD -15.6%
Inventory, Net 2.27B USD -9.25%
Other Assets, Current 851M USD +38.2%
Assets, Current 7.97B USD +12.1%
Deferred Income Tax Assets, Net 331M USD -63.8%
Property, Plant and Equipment, Net 3.1B USD -4.63%
Operating Lease, Right-of-Use Asset 335M USD -14.1%
Intangible Assets, Net (Excluding Goodwill) 9.47B USD +15%
Goodwill 6.49B USD +4.27%
Other Assets, Noncurrent 638M USD -6.43%
Assets 28.3B USD +5.69%
Accounts Payable, Current 408M USD +15.2%
Employee-related Liabilities, Current 261M USD +14.3%
Liabilities, Current 3.18B USD +2.43%
Accrued Income Taxes, Noncurrent 165M USD -13.9%
Deferred Income Tax Liabilities, Net 118M USD -80%
Operating Lease, Liability, Noncurrent 311M USD -15.4%
Other Liabilities, Noncurrent 800M USD +43.6%
Liabilities 10.7B USD -2.01%
Accumulated Other Comprehensive Income (Loss), Net of Tax -238M USD -63.1%
Retained Earnings (Accumulated Deficit) 20.1B USD +8.23%
Stockholders' Equity Attributable to Parent 14.8B USD +10.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 17.6B USD +11%
Liabilities and Equity 28.3B USD +5.69%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 259M USD -53.1%
Net Cash Provided by (Used in) Financing Activities -23M USD +94.8%
Net Cash Provided by (Used in) Investing Activities -47.3M USD +28.3%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 170M shares +0.47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.76B USD +44.5%
Deferred Tax Assets, Valuation Allowance 1.01B USD -20.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 421M USD -14.2%
Depreciation 284M USD +5.58%
Payments to Acquire Property, Plant, and Equipment 37.1M USD -19.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.44B USD +21.3%
Lessee, Operating Lease, Liability, to be Paid 505M USD -14.7%
Property, Plant and Equipment, Gross 5.85B USD +2.45%
Operating Lease, Liability, Current 86.4M USD -4.32%
Lessee, Operating Lease, Liability, to be Paid, Year Two 88.5M USD -7.91%
Lessee, Operating Lease, Liability, to be Paid, Year One 103M USD -2.64%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -27.8M USD -170%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 83.8M USD -17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 88.3M USD +5.75%
Deferred Tax Assets, Operating Loss Carryforwards 1.36B USD -20.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 8M shares 0%
Unrecognized Tax Benefits 186M USD +7.44%
Lessee, Operating Lease, Liability, to be Paid, Year Four 50.2M USD -41.7%
Additional Paid in Capital 714M USD +75.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 127M USD +46.6%
Depreciation, Depletion and Amortization 183M USD +24.2%
Deferred Tax Assets, Net of Valuation Allowance 2.93B USD +0.02%
Share-based Payment Arrangement, Expense -302M USD -9.88%
Interest Expense 252M USD -5.04%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%